OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Advisory Board and Contents	261
Subscription and Copyright Information	214
Subscription and Copyright Information	209
Advisory Board and Contents	187
Stories in Molecular Medicine December 2021	178
Advisory Board and Contents	168
m6A and beyond: RNA modifications shaping angiogenesis	163
Subscription and Copyright Information	142
Advisory Board and Contents	123
Subscription and Copyright Information	106
Subscription and Copyright Information	105
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy	104
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates	101
Fc-optimized checkpoint antibodies for cancer immunotherapy	99
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	94
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	90
Neutrophils and extracellular traps in crystal-associated diseases	87
Consideration of the importance of measuring thermal discomfort in biomedical research	81
Pushing the boundaries of brain organoids to study Alzheimer’s disease	78
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	76
Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors	76
Opportunities and challenges for biomarker discovery using electronic health record data	75
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines	74
d-Amino acids: new clinical pathways for brain diseases	72
Beneath the radar: immune-evasive cell sources for stroke therapy	68

Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	67
Subscription and Copyright Information	65
Brain-specific regulatory T cell expansion limits cognitive decline	64
Stories in Molecular Medicine November 2021	64
Erythropoietic protoporphyrias: updates and advances	63
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	62
iPSCs and DRGs: stepping stones to new pain therapies	61
In Utero Gene Therapy: Progress and Challenges	59
Molecular mechanisms in the pathogenesis of dengue infections	55
Engineering cytokines for tumor-targeting and selective T cell activation	54
Amyloid and collagen templates in aortic valve calcification	53
Insights from HIV-1 vaccine and passive immunization efficacy trials	53
Keratinocytes: new perspectives in inflammatory skin diseases	52
Acquired resistance to immunotherapy in solid tumors	52
Cell-free circulating tumor DNA profiling in cancer management	49
Emerging roles of cyclin-dependent kinase 7 in health and diseases	47
Microbes and mood: innovative biomarker approaches in depression	46
Advisory Board and Contents	45
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	45
Hormesis as an adaptive response to infection	44
Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation	44